Back to Neurology

OUR EXPERTISE AND AND SERVICES AVAILABLE IN

Emerging Neurology

Overview

Spherix’s coverage of emerging neurology indications focuses on evolving markets where a paradigm shift is expected in the coming years.

Services Available

Prepping for the pipeline

  • Amyotrophic Lateral Sclerosis (US)

Benchmarking new brand performance

  • Aducanumab (Biogen) in Alzheimer’s Disease (US)*

*Pending approvals and launch

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Emerging Neurology Coverage